yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q40968003-2678737C-DB4F-4257-99B6-07D76C3C3FDA
Q40968003-2678737C-DB4F-4257-99B6-07D76C3C3FDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40968003-2678737C-DB4F-4257-99B6-07D76C3C3FDA
Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.
P2860
Q40968003-2678737C-DB4F-4257-99B6-07D76C3C3FDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40968003-2678737C-DB4F-4257-99B6-07D76C3C3FDA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1097892dd790499c2ca34226e41ddb06c46aafb3
P2860
BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.